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Abstract 
Objectives: Physiotherapy treatment for pelvic floor dysfunction in women produces 
variable outcomes, and discovering predictors of outcome is important for developing service 
provision and treatment planning.  The study aimed to determine whether patient motivation 
impacts treatment compliance and outcome for physiotherapy treatment in a cohort of 
patients with pelvic floor dysfunction. 
Design, setting and participants: A prospective observational study of 141 
consecutively referred adult female patients to the physiotherapy clinic of an 
urogynaecological outpatients unit at a UK hospital. 
Intervention: A 6-month (one group session per month) physiotherapy pelvic floor 
muscle training programme, which included a home-exercise programme. 
 Main outcome measures: Oxford Grading System and Queensland Pelvic Floor 
Questionnaire ratings of pelvic floor function were taken pre- and post-intervention, and the 
University of Rhode Island Change Assessment Scale assessed patient motivation-to-change 
pre-intervention.   
Results: Motivation-to-change predicted attendance at the intervention sessions, and 
also patient-rated pelvic symptoms improvements in function.  Patients with higher baseline 
motivation-to-change also reported greater patient-rated pelvic symptoms improvements, 
given the same clinician-rated muscle strength improvement in pelvic floor function.   
Conclusions: Patient motivation impacts physiotherapy treatment adherence and 
outcomes, and should be considered as part of future assessment/screening procedures. 
Clinical Trial Registration: NCT02549157. 
Keywords: motivation-to-change; clinician-reported outcome measure; patient-
reported outcome measure; attendance; pelvic floor dysfunction; PFMT. 
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Physiotherapy treatment for pelvic floor dysfunction in women can be effective1,2 and 
is also safe, acceptable, and cost-efficient3.  However, a consideration that prevents more 
widespread usage of physiotherapy treatment for this problem is that its outcomes can be 
variable4, and identifying the predictors of its success is a key objective for treatment 
development and service planning.  To date, there have been few studies that have explored 
these predictors.  It is known that physical dysfunction is not necessarily a primary predictor 
of physiotherapy outcome in this context5,6.  This stands in contrast to the role of 
psychological variables (e.g., depression, anxiety) that do appear to play a role in the positive 
prognosis for physiotherapy for pelvic floor dysfunction7,8.  However, the full range of 
psychological predictors of such treatment outcome is far from established, as there have 
been very few such investigations.   
The goal of the present investigation is to develop this under-researched area, and to 
explore whether a psychological variable – the patient’s motivation-to-change9 – which 
known to impact treatment outcomes in other areas, is implicated in the prognosis for 
physiotherapy treatment for pelvic floor dysfunction.  Physiotherapy treatment for pelvic 
floor dysfunction often takes the form of Pelvic Floor Muscle Training (PFMT) programmes.  
These PFMT programmes require active patient participation to achieve their impact – 
including attendance at classes, and often behaviour change to affect the desired outcomes.  
As patient participation (co-production) is central to the goals of the treatment, then the 
outcomes may well be subject to influence from the psychological characteristics of the 
patient7,8.  Given these considerations, the patient’s motivation-to-change seems to be a 
strong candidate for a psychological predictor of outcome for pelvic floor physiotherapy 
treatment8. 
The widely adopted Trans-theoretical Model (TTM) of intentional behaviour change9, 
suggests that an individual progresses through a number of ‘motivational stages’ before 
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behaviour change is achieved.  According to this model, there are four stages of the change 
process for an individual: Precontemplation is characterised by only a limited awareness of 
the problem, or, if the individual knows about the problem, a lack of intention to change; 
Contemplation involves an awareness of the problem, and often a consideration of the impact 
of that problem, but without any intention to act on these considerations; the Action stage 
comprises the individual modifying their behaviour as intended, often utilising aspects 
learned during the ‘contemplation’ stage; and the Maintenance stage involves a prolonged 
engagement with the behaviours needed to maintain any gains and/or avoid a return of the 
problem.  
This model has been shown to have strong predictive validity in many health settings, 
such as those involving treatment for alcohol abuse10,11, illicit drug use12-15, cigarette 
smoking16-18, criminal offending19, and excessive gambling20.  However, no work has been 
conducted in terms of exploring how such motivation-to-change may be used as a predictive 
tool for physiotherapy treatment for pelvic floor dysfunction.  It may be that patients who are 
not yet ready and motivated to commit to long-term physiotherapy treatment will not benefit 
from that intervention, and discovery of such patient predictors of outcome would be a step 
toward better matching treatment to patients at a point when they will most benefit from that 
treatment. 
To this end, the current study employed a prospective cohort design to assess the 
impact of patient motivation at intake on their compliance (as assessed by attendance at 
sessions) with a physiotherapy treatment for pelvic floor dysfunction.  In addition, it also 
examined the relationship between initial motivation-to-change and the outcomes of the 
intervention, as assessed both by a clinician-reported outcome measure (CROM) and a 
patient-reported outcome measure (PROM).  The use of both CROM and PROM of pelvic 
floor function is important, as, irrespective of the change in function from the clinician’s 
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perspective, the patient’s perception of that change is critical in assessing the outcome of the 
intervention21.  It may well be that there is no necessary relationship between the two22; a 
finding that has been reported in other conditions23.  The use of the motivation-to-change 
scale allows investigation of another issue in the context of the impact of this patient variable 
on PFMT outcomes.  If a patient has higher motivation-to-change, then it has been suggested 
that they will tend to perceive smaller changes in clinician-rated outcomes more positively 
than those lacking in this motivation24.  Theoretically, the presence of a motivational state in 
behavioural psychology is often termed an establishing operation for sensitivity to 
environmental changes connected to that state25.  Given this, it might be expected that there 
may be differences in pelvic floor outcomes when measured by clinician-rated and patient-
rated assessments, with patients expressing higher motivation-to-change reporting greater 
patient-rated benefits from smaller clinician-rated changes.   
In summary, the study aimed to determine whether patient motivation impacts 
treatment compliance and outcome for physiotherapy treatment, and whether it impacts 
patient perception of clinician-rated changes in muscle strength, in a cohort of patients with 




Of 202 consecutively-referred adult female patients to the urogynaecological 
physiotherapy outpatients’ service at an NHS teaching hospital, who were invited to 
participate, 141 patients agreed and completed the questionnaires.  The mean age and 
standard deviation of the participants was 52 (SD = 13, range = 21 – 86) years.  Participants 
were referred with either a single or combination of symptoms: 22/141 (16%) stress 
incontinence; 7/141 (5%) urge incontinence; 55/141 (39%) mixed incontinence; 4/141 (3%) 
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faecal incontinence; 21/141 (15%) prolapse alone; and 32/141 (23%) prolapse with 
incontinence.  Patients referred for third and fourth degree perineal tears, post-operative 
rehabilitation, or urogynaecological indications were excluded from the study.  The mean 
BMI of the patients was 30.02 (SD 6.96; range = 18.00 – 62.90).     
 
Materials 
Modified Oxford Grading26 is a validated clinician-rated assessment that quantifies 
the strength of pelvic floor contraction.  Patients are scored from 0-5, where 0 is no pelvic 
floor contraction and 5 is very strong: elevation of examiner's finger against strong 
resistance27,28. 
Queensland Pelvic Floor Questionnaire29 is a validated patient-rated female pelvic 
floor questionnaire.  It has sections related to bladder dysfunction, bowel dysfunction, 
prolapse, and sexual dysfunction.  Each of the subscales produces a score from 0 to 10, and 
the sum of the scores gives an overall pelvic floor dysfunction (range 0 – 40).  Greater scores 
represent worse function.  The internal reliability (Cronbach α) of the scales range between 
0.72 and 0.9530.  Analyses of the item responses to the overall scale for the present sample 
produced an internal reliability (α) of 0.81.  
 University of Rhode Island Change Assessment Scale (URICA)31 is a commonly 
used self-assessment designed to measure an individual’s motivation-to-change their 
behaviour.  It consists of 32 statements that participants endorse on a 5-point scale (strongly 
agree to strongly disagree).   The items load on four scales, including: Precontemplation, 
Contemplation, Action, and Maintenance, and each scale gives a score between 0 (low on 
that dimension) and 7 (high on that dimension).  The sum of the scores for Contemplation, 
Action, and Maintenance minus Precontemplation gives a Readiness-to-change score.  The 
internal reliability (α) for the scales has been reported to range between .88 and .8926.  
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Analyses of the responses to the items in the scales for the present sample produced internal 
reliabilities (α) of: Precontemplation = .81; Contemplation = .94; Action = .92; and 
Maintenance = .86, with the overall α = .92.    
 
Intervention 
The physiotherapy treatment consisted of 2 individual appointments, and 6 x 60min 
group sessions (7-8 patients per group), over a 6 month period.  The individual appointments 
were taken by one of the clinical physiotherapists, and were held at the start and end of the 
PFMT programme.  These individual appointments involved vaginal examination to assess 
vaginal muscles and tissues and pelvic floor strength, in order to assess the patient’s pelvic 
floor exercise technique quality.  The PFMT group-based programme provided training in 
pelvic floor exercises and in identifying and isolating correct muscle groups, as well as 
educating patients about the anatomy and function of the pelvic floor muscles and the 
lumbosacral spine region.  Group sessions were led by a clinical physiotherapy specialist, a 
senior physiotherapist in women’s health, a surgical nurse specialist, or a psycho-sexual 
counsellor, as appropriate, who each saw all groups, and were not assigned to one particular 
group.  The sessions also were structured to provide information and enhance awareness 
regarding: (1) the anatomy and function of the pelvic floor muscles; (2) back and spinal care, 
as well as posture; (3) medical and surgical management of pelvic floor conditions; (4) 
psycho-sexual issues; (5) the anatomy of the intestines and bowel, and colorectal problems; 
and (6) physiotherapy management of Pelvic Floor Dysfunction (PFD) and available aids.  In 
addition, each session provided training in pelvic floor exercises and advice about the 
behavioural management of continence, such as fluid intake, bladder drill, how to contract 
pelvic floor muscles before and during increases in abdominal pressure (‘the knack’), double 
voiding, and helpful activities.   
                                                                Patient motivation and physiotherapy outcomes  -  8 
 
Patients were directed to practice the exercises at home, on a daily basis (mornings 
and evenings), between the hospital sessions.  At the start of the programme, the patients 
were advised to start with 5 rapid squeezes of their pelvic floor muscles, holding each 
squeeze between 1-3s, if possible, and then releasing.  Patients were encouraged to 
progressively increase the number and duration of squeezes over the course of the 
programme, but to primarily focus on the quality of their technique.  The goal was to 
accomplish 10 long squeezes, holding for up to 10s, followed by 10 short squeezes, at least 
two to three times a day. 
           
Procedure 
On admittance, the participants underwent assessment of their pelvic floor strength by 
a clinician using the Modified Oxford Grading system.  The same clinician rated all patients 
at both time points.  Participants also provided their assessments of their condition using the 
Queensland Pelvic Floor Questionnaire.  They also gave data regarding other demographic 
characteristics.  In addition, the participants also completed a questionnaire to assess their 
Readiness-to-change (URICA).  The participants then progressed through the programme, 
attending one session every month for the six months.  On completion of the programme, the 
clinician-rated (Modified Oxford Grading) and patient-rated (Queensland Pelvic Floor 
Questionnaire) assessments of pelvic floor function were repeated.  
 
Analyses Plan 
After assessment of the descriptive statistics, two sets of analyses were planned.  A 
series of stepwise regressions were conducted to determine whether patients’ readiness-to-
change (sum of Contemplation, Action, and Maintenance, minus the Precontemplation) 
predicted treatment outcomes: completion of the PFMT programme; change in clinician-rated 
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muscle strength (Oxford); and change patient-rated pelvic symptoms (Queensland).  In all 
cases, patient age, patient BMI, clinician-rated intake muscle strength (Oxford), and patient-
rated intake pelvic symptoms, were entered in step 1, and readiness-to-change was entered in 
the step 2 to assess its independent contribution.  For completion, this was a logistic 
regression as the outcome is a binary variable (completion versus non-completion), for 
change in clinician- and patient-rated symptoms, multiple regressions were conducted.  In 
addition, for each of the three outcomes, as the readiness-to-change score does not allow 
separate assessment of each change scale, multiple regressions were conducted using the four 
subscales of the URICA as predictors of each outcome.  To assess whether readiness-to-
change impacted patient perception of symptom improvement, the relationship between 
change in patient-rated pelvic symptom (Oueensland) and change in clinician-rated muscle 




Table 1 about here 
---------------------------- 
Table 1 shows the means (standard deviations) for the clinician-rated (Oxford) and 
patient-rated (Queensland) assessments of pelvic floor function for the whole sample, as well 
as separately for the patients who attended all of the sessions in the PFMT programme 
(completers), and for the patients who did not (non- completers).  There were 68/141 (48%) 
completers, and 73/141 (52%) non-completers.  Those who completed the PFMT programme 
had less severe clinician-rated pelvic floor muscle weakness (Oxford) at intake, compared to 
those who did not complete the programme.  However, patient-rated pelvic floor function 
(Queensland) did not differ between the two groups at intake.  For those patients who 
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completed the sessions, there was a statistically significant improvement in clinician-rated 
(Oxford) muscle strength over the course of treatment (intake mean = 2.55, SD = .73; end-
point mean = 3.08, SD = .0.83; t(67) = 4.42, p < .001, d = .61).  There was also a statistically 
significant improvement in patient-assessment (Queensland) muscle strength (intake mean = 
31.98, SD = 13.40; end-point mean = 26.32, SD = 13.79; t(67) = 2.24, p < .05, d = . 29).     
------------------------- 
Table 2 about here 
------------------------- 
Table 2 shows the means (standard deviations) for the four stages of change scales, 
Precontemplation, Contemplation, Action, and Maintenance (URICA).  It also shows their 
correlations with the patients’ age, BMI, clinician-rated muscle strength (Oxford), and 
patient-rated pelvic symptoms (Queensland), at intake.  Inspection of these data shows no 
significant relationships between any of the stages of change scores and patient age, patient 
BMI, clinician-rated muscle strength (Oxford), or patient-rated pelvic symptoms 
(Queensland).  The only exception was a small positive relationship between contemplation 
scores and BMI. 
 
Motivation-to-change 
Completion: The addition of readiness-to-change as step 2 of a stepwise logistic 
regression produced a significant increase in predictive accuracy of completion, -2LL = 
61.62, X2(1) = 4.22, p = .040.  Of the individual predictors, readiness-to-change (β = .470, p = 
.050, odds ratio = 1.597), and BMI (β = -.104, p = .029, odds ratio = .902), were significant 
independent predictors of completion; but age (β = -.038, p = .160, odds ratio = .962), 
clinician-rated intake muscle strength (β = .603, p = .108, odds ratio = 1.828), and patient-
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rated intake pelvic symptoms (β = -.037, p = .142, odds ratio = .964), were not significantly 
related to completion.   
When the four readiness-to-change subscales were used as predictors of completion, 
the logistic regression was significant, -2LL = 185.44, X2(4) = 9.66, p = .046.  Of the 
individual predictors, Action (β = .984, p = .018, odds ratio = 2.675) was a significant 
independent predictor of completion; but Precontemplation (β = -.171, p > .30, odds ratio = 
.843), Contemplation (β = -.394, p > .30, odds ratio = .874), and Maintenance (β = -.501, p = 
.083, odds ratio = .606), were not significantly related to completion. 
Clinician-rated muscle strength (Oxford): The addition of readiness-to-change as 
step 2 of a stepwise multiple regression did not produce a significant increase in predictive 
accuracy of completion, change R2 = .028, F(1,24) = 1.68, p = .207.  Of the individual 
predictors, clinician-rated intake muscle strength (β = -1.038, p < .001) was a significant 
independent predictors of change in clinician-rated muscle strength; but age (β = -.013, p > 
.30), BMI (β = -.018, p > .30), patient-rated intake pelvic symptoms (β = .006, p > .30), and 
readiness-to-change (β = .114, p = .207), were not significantly related to change in clinician-
rated muscle strength.   
When the four readiness-to-change subscales were used as predictors of change in 
clinician-rated muscle strength, the multiple regression was not significant, R2 = .059, F < 1.  
None of the individual predictors were significantly related to change in clinician-rated 
muscle strength: Precontemplation, β = -.010, p > .30; Contemplation, β = .215, p > .30; 
Action, β = .178, p > .30; Maintenance, β = -.275, p = .238. 
Patient-rated pelvic symptoms change: The addition of readiness-to-change as step 2 
of a stepwise multiple regression produced a significant increase in predictive accuracy of 
completion, change R2 = .246, F(1,17) = 8.82, p = .032.  Of the individual predictors, 
readiness-to-change (β = 1.137, p = .045) was a significant independent predictors of change 
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in patient-rated muscle strength; but age (β = .063, p > .30), BMI (β = -.269, p > .30), 
clinician-rated intake muscle strength (β = 1.232, p > .30) , and patient-rated intake pelvic 
symptoms (β = .006, p > .30), were not significantly related to change in patient-rated muscle 
strength.   
When the four readiness-to-change subscales were used as predictors of change in 
patient-rated muscle strength, the multiple regression was not significant, R2 = .135, F(4,45) 
= 1.68, p = 1.71.  Of the individual predictors, Action (β = 6.803, p = .043) was significantly 
related to change in patient-rated pelvic symptoms; but Precontemplation (β = 1.860, p > 
.30), Contemplation (β = -.634, p > .30), and Maintenance (β = -1.151, p > .30) were not 
significantly related to change in patient-rated pelvic symptoms. 
 
Perception of Change 
A regression analyses determined the degree to which changes in clinician-rated 
muscle strength (Oxford) were related to changes in patient-rated pelvic symptoms 
(Queensland).  This regression produced a non-significant model: Queensland change = -2.15 
-.66(Oxford change), r2 = .007, p > .60.  However, when the sample was split into those 
whose scores were below or above 11 on the readiness-to-change scale (indicating those at 
the Precontemplation or Contemplation stages, or those at the Action or Maintenance 
stages)31, the relationship between the clinician-rated muscle strength changes and patient-
rated pelvic symptoms changes was found to be different in the two groups.  For those at a 
lower stage of readiness-to-change (n = 122), the regression model was found to be: 
Queensland change = .56 – 4.35*(Oxford change); which was statistically significant, r2 = 
.304, p < .01.  For those at a higher stage of readiness-to-change (n = 19), the regression 
model was found to be: Queensland change = -8.00 + 6.00*(Oxford change); which was 
statistically significant, r2 = .460, p < .05.  The difference in the beta values of the two 
                                                                Patient motivation and physiotherapy outcomes  -  13 
 
regression models (-4.35 for the lower readiness versus +6.00 for the higher readiness-to-
change) suggests that, for any given change in the clinician-rated muscle strength change, a 
much greater chance of change in the patient-rated pelvic symptoms occurred for the higher 
motivation group.  The difference between the two beta values was found to be statistically 




The current study aimed to determine whether patient motivation-to-change would 
impact attendance and outcomes in a physiotherapy intervention for pelvic floor dysfunction.  
The findings were that the PFMT programme produced statistically significant improvements 
in both clinician-rated muscle strength and patient-rated pelvic symptoms, in line with 
previous findings1,4,7.  However, motivation-to-change impacted both attendance at the PFMT 
sessions, and patient-rated pelvic symptoms.  Those with higher levels of readiness-to-change 
were more likely to attend all of the PFMT sessions, and were more likely to report greater 
patient-rated pelvic symptom improvements.  This was particularly true for those at the 
Action stage of change; where the recognition of a problem and the intention to overcome the 
problem have translated into behaviour9.  However, there was no such relationship with the 
clinician-rated muscle strength change in pelvic floor function.       
These findings relating motivation-to-change and attendance and outcomes for PFMT 
are novel for this treatment, but they are similar to those obtained from other patient 
populations10,32,33.  Given this, the results suggest that the patient’s motivation may be a 
significant factor in determining the likelihood of that patient benefiting from the PFMT 
programme.  At the very least, if a patient does not have the necessary motivation-to-change, 
they will simply not attend the classes, and will most likely not show any improvements in 
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pelvic floor function.  This finding, coupled with previous explorations of the impact of 
motivational interviewing on PFMT outcomes8, imply that more focus should be given to 
these psychological variables in assigning patients to different treatment regimes for pelvic 
floor function.  In addition, providing adjunct psychological support in addition to the PFMT 
for patients undergoing such treatment may be beneficial8.    
Research into the impacts of psychological variables on physiotherapy treatments for 
pelvic floor dysfunction is at an early stage, but there are a number of studies that have shown 
the importance of considering these factors5,7,8.  For example, studies7 have demonstrated that 
higher pre-treatment depression scores are associated with poor outcomes for physiotherapy 
treatments for pelvic floor dysfunction, and have noted that patient health values also predict 
compliance and outcomes for this treatment. 
An additional finding from the current study was that, when motivation-to-change 
was higher, patients reported greater patient-rated pelvic symptom improvements for the 
same improvement change in the clinician-rated muscle strength.  This finding was predicted 
from the theoretical literature relating motivation to perceived outcomes24,25, but has not until 
this current study actually been empirically demonstrated in this (nor in any other) context.  
Apart from the theoretical interest that this finding produces, it also has some practical 
implications.  If patients’ motivation-to-change is enhanced prior to, or even during, PFMT8, 
then it may be that any clinician-rated muscle strength changes that are brought about by the 
programme would be perceived more positively by the patients.  This should increase patient-
rated pelvic symptom assessment, and their satisfaction with the treatment.  In turn, this may 
drive a ‘virtuous circle’ of positive feedback; meaning these patients engage more (better 
comply) with their PFMT.  Moreover, to the extent that patients’ satisfaction with the 
outcome and their self-assessment of their pelvic floor functioning is at least as important as 
any clinician-rated muscle strength changes in this functioning, this would be a notable 
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achievement.  The fact that motivation-to-change has an ‘amplifying effect on subject 
assessments of improvement, might go some way towards explaining why this former 
variable was somewhat more strongly related to patient-rated pelvic symptoms than clinician-
rated muscle strength change scores.  Of course, patients with higher motivation-to-change 
may also subjectively feel more negatively towards any reduction in functioning that may 
experience.        
The concept of patient motivation-to-change is relatively new in a medical context, 
although its importance in other health-related fields is recognised.  Clearly, measuring this 
construct will need further development, and finding appropriate questionnaires is still an 
issue to be considered.  The current URICA  has an advantage in that it shows strong validity 
in a variety of contexts, however, anecdotal reports from the participants suggested that they 
found the questionnaire too long (32 questions) and somewhat intrusive.  This might limit its 
usefulness, in its full form, in a medical assessment context.  It is also important to note that 
the choice of the other instruments that assess clinician-rated and patient-rated assessments of 
pelvic health may have influenced the current results.  Further studies using a range of 
different assessment tools would further explore these relationships to extend the validity of 
the finding, or to point to their limits of generalizability.   
In the current study, approximately 50% of patients attended all of the classes.  This 
figure appears quite low, although a recent survey of PFMT programmes in the UK suggested 
a mean NHS attendance was just below 75%, but with a very large variance (attendance at 
private health centres was approximately 85%)34.  Of course, this nonattendance figure 
includes those who may have attended for some of the 6 classes in the programme, but not 
all, so is a conservative estimate of attendance.  Nevertheless, finding ways to enhance this 
figure, which may include increasing motivation-to-change, would have potentially strong 
benefits for patients and services.  This is thrown into sharper contrast by considering that 
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only 19/141 patients had a high readiness-to-change score, compared to 122/141 patients with 
a low readiness-to-change score.  This may reflect the sample chosen, but is probably 
reflective of patients referred to public health services in general.   
A limitation to the current study was that adherence to the home exercise programme 
(HEP) was not directly measured.  As the HEP was part of the intervention, data on 
adherence would be useful in future studies to add extra information.  It may be that HEP is a 
different form of PFMT, with different motivational factors associated with it compared to 
class attendance.  There are a number of ways in which this could be measured, including a 
range of available apps – although all suffer from the problems of self-report. 
  In summary, the current research is amongst the first that has identified that patient 
motivation may play a role in treatment compliance and outcomes.  These findings suggest 
that a fuller assessment of the psychological functioning of patients would facilitate treatment 
regimes in the field of physiotherapy and pelvic floor functioning. In addition to this, 
motivation assessment may play a role in future screening by providing practitioners the 
ability to predict the relative likelihood of patients completing their physiotherapy 
programme, and providing better treatment provisions for the patient, allowing customised 
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Contribution of the Paper 
 
• The study determined whether patient motivation impacts treatment compliance and 
outcome for physiotherapy treatment in a cohort of patients with pelvic floor 
dysfunction. 
• Patients with higher baseline motivation-to-change also reported greater PROM 
pelvic symptoms improvements, given the same CROM muscle strength improvement 
in pelvic floor function. 
• Patient motivation impacts physiotherapy treatment adherence and outcomes, and 
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Table 1: Means (and standard deviations) for the clinician-rated muscle strength 
(Oxford) and patient-rated pelvic symptoms (Queensland) assessments of pelvic floor 
function for the whole sample, completers, and non-completers, at the intake point.  
 
--------------------------------------------------------------------------------------------------------  
Cohort   Non-completers  Completers    t d        
(n = 114)               (n = 73)      (n = 68) 
-------------------------------------------------------------------------------------------------------- 
Oxford    2.38   (0.88)       2.11  (1.05)    2.55   (0.73)  2.33* .50 
Queensland 33.31 (15.67)     34.23 (14.97)  31.98 (13.40)  < 1       .07 
--------------------------------------------------------------------------------------------------------- 
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Table 2: Means (standard deviations) for the stages of change (URICA) scales, along 
with their correlations with the patients’ age, BMI, clinician-rated muscle strength 
(Oxford), and patient-rated pelvic symptoms (Queensland) at intake. 
 
-------------------------------------------------------------------------------------------------- 
        Mean (SD)  Age   BMI     Oxford Queensland 
-------------------------------------------------------------------------------------------------- 
Precontemplation   2.23  (0.80)  .067   -.077        -.029    -.030  
Contemplation        3.86  (0.81) -.056    .210*        .052     .126 
Action                     3.83  (0.73) -.082    .162         .066    -.077 
Maintenance         3.25  (0.83)  .096    .178        -.077     .068 
Readiness         8.70  (2.12) -.036    .243*       -.006     .109 
--------------------------------------------------------------------------------------------------- 
* p < .05; ** p < .01; *** p < .001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
